Protagenic Therapeutics, Inc. (PTIXW)
PTIXW Stock Price Chart
Explore Protagenic Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze PTIXW price movements and trends.
PTIXW Company Profile
Discover essential business fundamentals and corporate details for Protagenic Therapeutics, Inc. (PTIXW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
27 Apr 2021
Employees
1.00
Website
http://www.protagenic.comCEO
Garo H. Armen
Description
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.
PTIXW Financial Timeline
Browse a chronological timeline of Protagenic Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 Sept 2023
EPS came in at -$0.32 .
Earnings released on 30 Jun 2023
EPS came in at -$0.28 .
Earnings released on 31 Mar 2023
EPS came in at -$0.17 .
Earnings released on 31 Dec 2022
EPS came in at -$0.14 .
PTIXW Stock Performance
Access detailed PTIXW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.